ConductScience.org, home

Trial · NCT05122208

Famotidine in Covid-19 Intensive Care Unit

NCT05122208, Completed, Istanbul Medeniyet University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Famotidine in Covid-19 Intensive Care Unit. Trials, record NCT05122208. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05122208

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Famotidine in Covid-19 Intensive Care Unit
NCT number
NCT05122208
Status
Completed
Enrollment
60 participants, actual
Lead sponsor
Istanbul Medeniyet University
Conditions
COVID-19 Pandemic
Interventions
Famotidine Tablets
First posted
2021-11-16
Last updated
2022-04-19

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of patients who died in intensive careWithin 17 days from the patient's admission to the intensive care unit or if he dies within this period, to this dateMortality in intensive care
PrimaryNumber of patients who were intubated in intensive careWithin 17 days from the patient's admission to the intensive care unit or if he dies within this period, to this dateDevelopment of respiratory distress requiring intubation in the patient
SecondaryFerritinWithin 17 days from the patient's admission to the intensive care unit or if he dies within this period, to this dateFerritin in nonogram/miiliter
SecondaryCRPWithin 17 days from the patient's admission to the intensive care unit or if he dies within this period, to this dateC-Reactive protein in miligram/liter
SecondaryD-DimerWithin 17 days from the patient's admission to the intensive care unit or if he dies within this period, to this dateD-Dimer in nonogram/miiliter
SecondaryFibrinogenWithin 17 days from the patient's admission to the intensive care unit or if he dies within this period, to this dateFibrinogen in nonogram/miiliter
SecondaryProcalcitoninWithin 17 days from the patient's admission to the intensive care unit or if he dies within this period, to this dateProcalcitonin in nonogram/miiliter

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05122208

GET https://conductscience.org/api/trials/v1/NCT05122208/registered